Gene · 338413
Papers2,372
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
541 to 560 of 2,372
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mechanical Stress-Induced IGF-1 Facilitates col-I and col-III Synthesis via the IGF-1R/AKT/mTORC1 Signaling Pathway. | Stem Cells Int | 2021 | 34912459 | PubTator, text mining | PubMed |
| In situ functional cell phenotyping reveals microdomain networks in colorectal cancer recurrence. | Cell Rep Methods | 2021 | 34888541 | PubTator, text mining | PubMed |
| Histopathological and Molecular Profiling of Clear Cell Sarcoma and Correlation with Response to Crizotinib: An Exploratory Study Related to EORTC 90101 "CREATE" Trial. | Cancers (Basel) | 2021 | 34885165 | PubTator, text mining | PubMed |
| DNA Methylation in Huntington's Disease. | Int J Mol Sci | 2021 | 34884540 | PubTator, text mining | PubMed |
| Serum from Older Adults Increases Apoptosis and Molecular Aging Markers in Human Hippocampal Progenitor Cells. | Aging Dis | 2021 | 34881092 | PubTator, text mining | PubMed |
| Phosphorylation of ribosomal protein S6 differentially affects mRNA translation based on ORF length. | Nucleic Acids Res | 2021 | 34871442 | PubTator, text mining | PubMed |
| A Novel Loss-of-Function Mutation in the NPRL3 Gene Identified in Chinese Familial Focal Epilepsy with Variable Foci. | Front Genet | 2021 | 34868250 | PubTator, text mining | PubMed |
| Mass Cytometry in Hematologic Malignancies: Research Highlights and Potential Clinical Applications. | Front Oncol | 2021 | 34858804 | PubTator, text mining | PubMed |
| Clinical Development of AKT Inhibitors and Associated Predictive Biomarkers to Guide Patient Treatment in Cancer Medicine. | Pharmgenomics Pers Med | 2021 | 34858045 | PubTator, text mining | PubMed |
| Design, Synthesis, and Evaluation of Potent, Selective, and Bioavailable AKT Kinase Degraders. | J Med Chem | 2021 | 34855399 | PubTator, text mining | PubMed |
| RUNX1/EGFR pathway contributes to STAT3 activation and tumor growth caused by hyperactivated mTORC1. | Mol Ther Oncolytics | 2021 | 34853810 | PubTator, text mining | PubMed |
| A DAP5/eIF3d alternate mRNA translation mechanism promotes differentiation and immune suppression by human regulatory T cells. | Nat Commun | 2021 | 34848685 | PubTator, text mining | PubMed |
| Deep phenotyping of T cell populations under long-term treatment of tacrolimus and rapamycin in patients receiving renal transplantations by mass cytometry. | Clin Transl Med | 2021 | 34841735 | PubTator, text mining | PubMed |
| Fatty acid synthase as a feasible biomarker for triple negative breast cancer stem cell subpopulation cultured on electrospun scaffolds. | Mater Today Bio | 2021 | 34841239 | PubTator, text mining | PubMed |
| Multicentric Castleman disease and the evolution of the concept. | Pathologica | 2021 | 34837092 | PubTator, text mining | PubMed |
| Natural Products for Pancreatic Cancer Treatment: From Traditional Medicine to Modern Drug Discovery. | Nutrients | 2021 | 34836055 | PubTator, text mining | PubMed |
| The Molecular Basis for Erns Dimerization in Classical Swine Fever Virus. | Viruses | 2021 | 34835010 | PubTator, text mining | PubMed |
| A Rational Design of α-Helix-Shaped Peptides Employing the Hydrogen-Bond Surrogate Approach: A Modulation Strategy for Ras-RasGRF1 Interaction in Neuropsychiatric Disorders. | Pharmaceuticals (Basel) | 2021 | 34832880 | PubTator, text mining | PubMed |
| Cardiovascular Intervention in Neonates Using an Umbilical Vein Approach. | Children (Basel) | 2021 | 34828730 | PubTator, text mining | PubMed |
| The JAK/STAT signaling pathway: from bench to clinic. | Signal Transduct Target Ther | 2021 | 34824210 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/338413/papers?page=28